Financials

News Discussions Technicals Forecast Seasonals

FLUO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

FluoGuide A/S is a clinical stage biotechnology company, which engages in the development of drugs used for the improvement of surgical outcomes by making cancer fluorescent. Its technology includes uPAR, fluorescent guidance to surgical oncologists, and photothermal treatment. The company was founded by Andreas Kjaer on January 30, 2018 and is headquartered in Copenhagen, Denmark.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

FLUO does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company